5.20
+0.30
+(6.12%)
At close: January 12 at 3:49:21 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 3 | 3 |
| Avg. Estimate | 7.72M | 792k | 24.91M | 4.29M |
| Low Estimate | 5.6M | 792k | 22.8M | 2.26M |
| High Estimate | 10.63M | 792k | 27.83M | 6.8M |
| Year Ago Sales | 4.8M | 6.86M | 4.8M | 24.91M |
| Sales Growth (year/est) | 60.80% | -88.45% | 419.01% | -82.76% |
Earnings History
| Currency in USD | 12/31/2023 | 9/30/2024 |
|---|---|---|
| EPS Est. | -0.01 | -0.01 |
| EPS Actual | -0.01 | 0 |
| Difference | 0 | 0.01 |
| Surprise % | 0.00% | 100.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BLRX.TA | -- | -- | -- | -- |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Related Tickers
LCTX.TA Lineage Cell Therapeutics, Inc.
217.10
+2.16%
BONS.TA Bonus BioGroup Ltd.
15.60
+2.63%
ORMP.TA Oramed Pharmaceuticals Inc.
870.30
+0.03%
CGEN.TA Compugen Ltd.
608.30
+3.15%
ENLV.TA Enlivex Therapeutics Ltd.
434.30
-0.11%
BSLN.SW Basilea Pharmaceutica AG
42.10
-1.75%
EVGN Evogene Ltd.
1.5700
-4.27%
CGEN Compugen Ltd.
1.6400
+3.14%
ALT1.MX Altimmune, Inc.
148.05
0.00%
2X1.F ABIVAX Société Anonyme
6.87
+0.29%